Sucampo and Takeda Initiate Global Pivotal Phase 3 Program of Lubiprostone in Pediatric Functional Constipation
Sucampo and Takeda Initiate Global Pivotal Phase 3 Program of Lubiprostone in Pediatric Functional Constipation
BETHESDA, Md. and DEERFIELD, Ill. — Sucampo Pharmaceuticals, Inc. ("Sucampo") and its development and commercialization partner Takeda Pharmaceuticals ("Takeda") today announced the …
Methadone Symptoms – Yahoo News Search Results
Find More Methadone Symptoms Information…